https://nucalahcp.com/copd/resources/video-library/
Watch videos about management of patients with COPD and NUCALA (mepolizumab) dosing and administration instructions.
video librarycopdnucalamepolizumab
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-outcome-of-us-fda-advisory-committee-recommending-approval-of-mepolizumab-for-the-treatment-of-adults-with-severe-asthma/
GSK announced outcome regarding the BLA for mepolizumab as an add-on maintenance treatment for severe asthma with eosinophilic inflammation.
of usadvisory committeegskannouncesoutcome
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-fda-approval-for-nucala-mepolizumab-for-use-in-adults-with-chronic-rhinosinusitis-with-nasal-polyps/
Fourth indication for mepolizumab in the US for eosinophil-driven diseases.
fda approvalgskannouncesnucalamepolizumab
https://www.gsk.com/en-gb/media/press-releases/gsk-receives-complete-response-letter-from-us-fda-for-use-of-mepolizumab-in-copd-patients/
GlaxoSmithKline plc(LSE/NYSE: GSK) today received a complete response letter (CRL) from the US FDA regarding its application for mepolizumab
complete response letterus fdafor usegskreceives